BR9610983A - Formas estáveis de administração farmacêuticas contendo paratormônio - Google Patents
Formas estáveis de administração farmacêuticas contendo paratormônioInfo
- Publication number
- BR9610983A BR9610983A BR9610983A BR9610983A BR9610983A BR 9610983 A BR9610983 A BR 9610983A BR 9610983 A BR9610983 A BR 9610983A BR 9610983 A BR9610983 A BR 9610983A BR 9610983 A BR9610983 A BR 9610983A
- Authority
- BR
- Brazil
- Prior art keywords
- parathormone
- pharmaceutical administration
- administration containing
- stable forms
- stable
- Prior art date
Links
- 102000003982 Parathyroid hormone Human genes 0.000 title 1
- 108090000445 Parathyroid hormone Proteins 0.000 title 1
- 239000000199 parathyroid hormone Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19538687A DE19538687A1 (de) | 1995-10-17 | 1995-10-17 | Stabile pharmazeutische Darreichungsformen enthaltend Parathormon |
| PCT/EP1996/004503 WO1997014429A1 (de) | 1995-10-17 | 1996-10-17 | Stabile pharmazeutische darreichungsformen enthaltend parathormon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9610983A true BR9610983A (pt) | 1999-03-02 |
Family
ID=7775105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9610983A BR9610983A (pt) | 1995-10-17 | 1996-10-17 | Formas estáveis de administração farmacêuticas contendo paratormônio |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0855917A1 (cs) |
| JP (1) | JPH11515002A (cs) |
| KR (1) | KR19990064322A (cs) |
| AU (1) | AU7294196A (cs) |
| BR (1) | BR9610983A (cs) |
| CA (1) | CA2234724A1 (cs) |
| CZ (1) | CZ108398A3 (cs) |
| DE (1) | DE19538687A1 (cs) |
| HU (1) | HUP9900751A3 (cs) |
| NZ (1) | NZ320237A (cs) |
| SK (1) | SK47298A3 (cs) |
| TR (1) | TR199800690T1 (cs) |
| WO (1) | WO1997014429A1 (cs) |
| ZA (1) | ZA968715B (cs) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19539574A1 (de) | 1995-10-25 | 1997-04-30 | Boehringer Mannheim Gmbh | Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren |
| DE19716154A1 (de) * | 1997-04-18 | 1998-10-22 | Boehringer Mannheim Gmbh | Stabile pharmazeutische Darreichungsform für Peptide, Proteine und Nukleinsäuren |
| MY120063A (en) † | 1997-12-09 | 2005-08-30 | Lilly Co Eli | Stabilized teriparatide solutions |
| US6770623B1 (en) | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
| SE9801495D0 (sv) * | 1998-04-28 | 1998-04-28 | Astra Ab | Protein formulationa |
| WO2001032201A2 (en) * | 1999-10-29 | 2001-05-10 | Eli Lilly And Company | A pharmaceutical composition having high cell membrane permeability |
| ES2368061T3 (es) * | 2000-02-08 | 2011-11-14 | Allergan, Inc. | Composiciones farmacéuticas de toxina botulínica. |
| CN100518819C (zh) * | 2000-06-30 | 2009-07-29 | 阿斯比奥制药株式会社 | 含有人甲状旁腺激素的药物成分及含有该成分的用于鼻内给药的药物组合物 |
| CN100353997C (zh) * | 2003-02-28 | 2007-12-12 | 中外制药株式会社 | 稳定的含蛋白质的制剂 |
| US20050032698A1 (en) * | 2003-07-14 | 2005-02-10 | Nps Allelix Corp. | Stabilized formulation of parathyroid hormone |
| KR100700869B1 (ko) * | 2005-06-03 | 2007-03-29 | 재단법인 목암생명공학연구소 | Ｐｔｈ, 완충제 및 안정제를 포함하는 안정한 ｐｔｈ조성물 |
| USRE49444E1 (en) | 2006-10-03 | 2023-03-07 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
| FR2947181B1 (fr) * | 2009-06-26 | 2012-05-04 | Lfb Biotechnologies | Composition de facteur vii |
| JPWO2012169435A1 (ja) | 2011-06-07 | 2015-02-23 | 旭化成ファーマ株式会社 | 高純度ｐｔｈ含有凍結乾燥製剤およびその製造方法 |
| EP3834824B1 (en) | 2014-03-28 | 2025-10-22 | Duke University | Treatment of an estrogen receptor positive breast cancer using a selective estrogen receptor modulator |
| CN113750091B (zh) | 2015-04-29 | 2025-03-11 | 雷迪厄斯制药公司 | 用于治疗癌症的方法 |
| JP6634758B2 (ja) * | 2015-09-25 | 2020-01-22 | ニプロ株式会社 | 液体組成物及び凍結乾燥製剤 |
| US10385008B2 (en) | 2017-01-05 | 2019-08-20 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD1901-2HCL |
| US10996208B2 (en) | 2017-04-28 | 2021-05-04 | Radius Health, Inc. | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
| CN110996988A (zh) * | 2017-09-22 | 2020-04-10 | 旭化成制药株式会社 | 稳定性优异的含有特立帕肽的液态药物组合物 |
| AU2019297421B2 (en) | 2018-07-04 | 2024-08-29 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD 1901-2HCL |
| CN113348163B (zh) | 2019-02-12 | 2024-10-08 | 雷迪厄斯制药公司 | 方法和化合物 |
| JP6947946B1 (ja) * | 2020-05-11 | 2021-10-13 | 旭化成ファーマ株式会社 | テリパラチド又はその塩を含有する安定な液状医薬製剤 |
| WO2021229835A1 (ja) * | 2020-05-11 | 2021-11-18 | 旭化成ファーマ株式会社 | テリパラチド又はその塩を含有する安定な液状医薬製剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816568A (en) * | 1986-05-16 | 1989-03-28 | International Minerals & Chemical Corp. | Stabilization of growth hormones |
| JP2739482B2 (ja) * | 1988-08-11 | 1998-04-15 | バイオ・チバ株式会社 | 安定なカルシトニン注射液の製造方法 |
| JPH0341033A (ja) * | 1989-07-07 | 1991-02-21 | Kyowa Hakko Kogyo Co Ltd | 安定なモチリン類含有製剤 |
| WO1993011785A1 (fr) * | 1991-12-09 | 1993-06-24 | Asahi Kasei Kogyo Kabushiki Kaisha | Composition a base d'hormone parathyroidienne stabilisee |
| DE4203040A1 (de) * | 1992-02-04 | 1993-08-05 | Boehringer Mannheim Gmbh | Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel |
-
1995
- 1995-10-17 DE DE19538687A patent/DE19538687A1/de not_active Withdrawn
-
1996
- 1996-10-16 ZA ZA9608715A patent/ZA968715B/xx unknown
- 1996-10-17 WO PCT/EP1996/004503 patent/WO1997014429A1/de not_active Ceased
- 1996-10-17 TR TR1998/00690T patent/TR199800690T1/xx unknown
- 1996-10-17 NZ NZ320237A patent/NZ320237A/xx unknown
- 1996-10-17 CA CA002234724A patent/CA2234724A1/en not_active Abandoned
- 1996-10-17 CZ CZ981083A patent/CZ108398A3/cs unknown
- 1996-10-17 HU HU9900751A patent/HUP9900751A3/hu unknown
- 1996-10-17 SK SK472-98A patent/SK47298A3/sk unknown
- 1996-10-17 KR KR1019980702819A patent/KR19990064322A/ko not_active Withdrawn
- 1996-10-17 AU AU72941/96A patent/AU7294196A/en not_active Abandoned
- 1996-10-17 BR BR9610983A patent/BR9610983A/pt not_active Application Discontinuation
- 1996-10-17 JP JP9515527A patent/JPH11515002A/ja active Pending
- 1996-10-17 EP EP96934715A patent/EP0855917A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990064322A (ko) | 1999-07-26 |
| SK47298A3 (en) | 1998-11-04 |
| TR199800690T1 (xx) | 1998-06-22 |
| HUP9900751A3 (en) | 2000-07-28 |
| HUP9900751A2 (hu) | 1999-07-28 |
| JPH11515002A (ja) | 1999-12-21 |
| AU7294196A (en) | 1997-05-07 |
| NZ320237A (en) | 1999-11-29 |
| WO1997014429A1 (de) | 1997-04-24 |
| CZ108398A3 (cs) | 1998-09-16 |
| EP0855917A1 (de) | 1998-08-05 |
| CA2234724A1 (en) | 1997-04-24 |
| ZA968715B (en) | 1998-04-16 |
| DE19538687A1 (de) | 1997-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9610983A (pt) | Formas estáveis de administração farmacêuticas contendo paratormônio | |
| NO981073L (no) | Farmasöytiske formuleringer inneholdende darifenacin | |
| PT843676E (pt) | Preparacoes medicamentosas contendo um enanteomero de brometo de ipratropio com duracao de accao prolongada | |
| ATE206924T1 (de) | Oral anzuwendende arzneizubereitung enthaltend olanzapin | |
| ATE243516T1 (de) | Amoxicillin und clavulanat enthaltende arzneizubereitungen | |
| FI955091L (fi) | Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät alkoholia ja hydrofobista lääkettä | |
| KR950703566A (ko) | 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] | |
| KR950700754A (ko) | 신규의 약물(novel medicament) | |
| ATE248594T1 (de) | Irbesartanhaltiges arzneimittel | |
| CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
| BR9611626A (pt) | Formulações farmacéuticas | |
| DK0754061T3 (da) | Ny oral farmaceutisk doseringsform | |
| KR970000221A (ko) | 약물 및 화장품의 국소 전달을 위한 트리코-형 파우치 | |
| FI945198L (fi) | Farmaseuttiset ja muut annosmuodot | |
| DE69632533D1 (de) | Intrapulmonare verabreichung vom hematopoietischem medikament | |
| NO981008D0 (no) | Farmasöytisk formulering | |
| NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
| ID22523A (id) | Formulasi aerosol obat yang mengandung budesonida | |
| BR9602915A (pt) | Medicamentos uso e formulação farmacêutica | |
| ITMI921123A0 (it) | Formulazioni farmaceutiche orali contenenti antocianosidi | |
| FI964619A7 (fi) | Epilepsialääkkeiden iholle annostelu | |
| ATE256465T1 (de) | Orale arzneimittel zubereitung von piperdinoalkanole in gelöster form | |
| FI973230L (fi) | Uusi farmaseuttinen formulaatio | |
| BR9610851A (pt) | Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto | |
| NO951933D0 (no) | Farmasöytiske formuleringer av ibuprofen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TC | Change of name | ||
| FA10 | Dismissal: dismissal - article 33 of industrial property law |